MAPT and Alzheimer disease: Moreover, the recent findings highlighted the unique vulnerability of humans to Alzheimer’s disease or primary tauopathy, and the amyloid-β and tau deposits formed in the brains from transgenic mouse models over 1–2 years are structurally different compared with those found in aged patients (113).